Biography: Daniel is the Northrop Professor of Medicinal Chemistry and Margaret Harvey Schering Land Grant Chair for Cancer Research at the University of Minnesota.  Dr. Harki received a B.A. in Biology and Chemistry from West Virginia University (1999), a Ph.D. in Chemistry from The Pennsylvania State University (2005), and performed postdoctoral research at the California Institute of Technology (2005-09). Dr. Harki began his academic career at the University of Minnesota (UMN) in 2009 as an Assistant Professor and was promoted to Associate Professor with tenure in 2016 and Professor in 2021. He was a Visiting Professor at ETH Zürich in 2019. Currently, Dr. Harki serves as the Associate Department Head for Research in the Department of Medicinal Chemistry and Director of the Small Molecule Initiative of the UMN Masonic Cancer Center. He is the Chair of Membership and International Relationships, and a member of the Executive Committee, for the American Chemical Society, Division of Medicinal Chemistry. Dr. Harki is a Fellow of the Royal Society of Chemistry (FRSC) and a Fellow of the American Association for the Advancement of Science (AAAS). Research in the Harki laboratory focuses on the development of small molecules to serve as mechanistic probes and therapeutics for applications in anticancer and antiviral research.